Stifel: Buy Vetrex, Checks Predict Strong Orkambi Launch By: Benzinga via Benzinga December 01, 2015 at 09:45 AM EST Shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) are up 9 percent year-to-date, but slipped below the $100 mark in ... Read More >> Related Stocks: Vertex Pharmaceuticals